FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16541611000001106: Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57860901000001114 Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57861001000001117 Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Co-beneldopa 25mg/100mg dispersible tablets sugar free 30 tablet true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start